Cargando…
Chronic Myeloid Leukemia in India
BACKGROUND: In the last decade, the use of imatinib has brought a paradigm shift in the management of chronic myeloid leukemia (CML). In India, imatinib has been available for more than a decade and has been made accessible to all segments of the population because of patient assistance programs and...
Autores principales: | Ganesan, Prasanth, Kumar, Lalit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493229/ https://www.ncbi.nlm.nih.gov/pubmed/28717743 http://dx.doi.org/10.1200/JGO.2015.002667 |
Ejemplares similares
-
Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009
por: Ganesan, Prasanth, et al.
Publicado: (2013) -
Symptom Burden and Quality of Life Issues among Patients of Chronic Myeloid Leukemia on Long-term Imatinib Therapy
por: Unnikrishnan, Radhika, et al.
Publicado: (2017) -
Chronic myeloid leukemia in India
por: Goldman, John M.
Publicado: (2013) -
Chronic myeloid leukemia data from India
por: Bansal, Shweta, et al.
Publicado: (2013) -
Chronic myeloid leukemia in children and adolescents: A single center experience from Eastern India
por: Raut, Lalit, et al.
Publicado: (2013)